Envoy Medical, Inc., trading under the ticker COCH on Nasdaq, is a Minnesota-based medical device company focused on fully implantable hearing systems, best known for its Esteem device. The company entered the public markets through a merger with Anzu Special Acquisition Corp I, sponsored by deep-tech investment firm Anzu Partners, whose SPAC completed its IPO in 2021. The November 2022 Form 10-Q filing, accession number 0001104659-22-118526, reflects one of the company's first quarterly reports as a combined public entity following the de-SPAC transaction earlier that year, with operations firmly in the medical device and hearing health sector. Sign up at SpacDesk for full filings, financials, and deal history on COCH and hundreds of other SPAC transactions.